Press release: Future Diagnostics celebrates 25th anniversary
On Friday, May 20, Future Diagnostics will celebrate its 25th anniversary. The company, which develops diagnostic tests on behalf of international biotech companies, will open its doors to invited guests that day. For a snack and a drink, the unveiling of its new logo and a tour of the laboratory in Wijchen.
Future Diagnostics proudly received the re-certification of ISO13485:2016 for the next 3 years. Zero non-conformities were found.
Development of Photonic Biosensor Device
Together with the BioCDx consortium, Future Diagnostics has been proudly working on the development of a miniaturized, reliable biosensing system for accurate and highly sensitive detection of protein cancer biomarkers, for the treatment monitoring of cancer disease and the therapeutics response.
Future Diagnostics Enters Agreement with DIAsource Immunoassays for Free 25OH Vitamin D ELISA product
DIAsource Immunoassays (Louvain-la-Neuve, Belgium), a BioVendor group company, has entered into a strategic agreement with Future Diagnostics (Wijchen, The Netherlands) under which Future Diagnostics will transfer all assets, with the exclusion of IP, related to Free 25OH Vitamin D ELISA product to DIAsource, securing its continued production and sales.
Top 10 IVD Solution Provider in Europe – 2020
We are very proud that Future Diagnostics Solutions is recognized by MedTech Outlook Magazine as TOP 10 In Vitro Diagnostic Solution Provider in Europe – 2020.
PhD promotion Giuliana Ascone – Euroclast
Future Diagnostics is proudly announcing the PhD promotion of Giuliana Ascone. Giuliana was ESR in the Marie Curie Euroclast project supported by Future Diagnostics and working at the Department of Experimental Rheumatology of the Radboud University.
Successful FDA inspection at Future Diagnostics
Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.
TTW funded Biomonitor project
Sensing technologies for acquiring real-time, precise, and reliable data are becoming more and more important in the field of healthcare, to help monitor, treat and coach patients. Future Diagnostics Solutions is proud to be a partner in the TTW funded Biomonitor project aiming at the development of continuous monitoring sensors.